Anthracycline-induced clinical heart failure in a cohort of 607 children: Long-term follow-up study

Journal of Clinical Oncology

Volumn 19, Issue 1, 2001, Pages 191-196

  Kremer, L C M ^a   Van Dalen, E C ^a   Offringa, M ^a   Ottenkamp, J ^a   Voute P A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; IFOSFAMIDE;

ADOLESCENT; ARTICLE; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0035155497     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.1.191     Document Type: Article

References (22)

1. A clinicopathologic analysis of adriamycin cardiotoxicity
2. Anthracycline induced cardiotoxicity
3. Risk factors for doxorubicin-induced congestive heart failure
4. Congestive heart failure due to adriamycin cardiotoxicity: Its natural history in children
5. Cardiac function in Wilms' tumor survivors
6. Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: A 10-year experience
7. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
8. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia
9. Increased risk of cardiac dysfunction after anthracyclines in girls
10. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer
11. Cardiac toxicity 4 to 20 years after completing anthracycline therapy
12. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience
13. Anthracycline-induced cardiomyopathy in children: A report of six cases
14. Anthracycline dose in childhood acute lymphoblastic leukemia: Issues of early survival versus late cardiotoxicity
15. Left ventricular diastolic function after anthracycline chemotherapy in childhood: Relation with systolic function, symptoms, and pathophysiology
16. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: A series of 15 patients
17. The cardiotoxicity of adriamycin and daunomycin in children
18. Late effects of treatment for Wilms' tumor: A report from the national Wilms' tumor study group
19. Regression models and life-tables
20. Nonparametric estimation from incomplete observations
21. Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer
22. Monitoring for anthracycline cardiotoxicity